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OBJECTIVE—To describe an etiologic approach to classiﬁcation of diabetes types in youth
based on the 1997 American Diabetes Association (ADA) framework, using data from the
SEARCH for Diabetes in Youth Study.
RESEARCH DESIGN AND METHODS—SEARCH conducted a comprehensive assess-
mentof2,291subjectsaged,20yearswithrecentlydiagnoseddiabetes.Usingautoimmunity(at
least one of two diabetes autoantibodies) and insulin sensitivity (equation validated against
hyperinsulinemic-euglycemic clamps) as the main etiologic markers, we described four catego-
ries along a bidimensional spectrum: autoimmune plus insulin-sensitive (IS), autoimmune plus
insulin-resistant (IR), nonautoimmune plus IS, and nonautoimmune plus IR. We then explored
how characteristics, including genetic susceptibility to autoimmunity (HLA genotypes), insulin
deﬁciency, and clinical factors varied across these four categories.
RESULTS—Mostsubjects fellintoeither theautoimmuneplus IS (54.5%) or nonautoimmune
plus IR categories (15.9%) and had characteristics that align with traditional descriptions of type
1or type 2diabetes. The group classiﬁed as autoimmune plus IR (19.5%) hadsimilar prevalence
and titers of diabetes autoantibodies and similar distribution of HLA risk genotypes to those in
the autoimmune plus IS group, suggesting that it includes individuals with type 1 diabetes who
are obese. The group classiﬁed as nonautoimmune plus IS (10.1%) likely includes individuals
with undetected autoimmunity but may also include those with monogenic diabetes and thus
requires further testing.
CONCLUSIONS—The SEARCH study offers researchers and clinicians a practical applica-
tion for the etiologic classiﬁcation of diabetes type and at the same time identiﬁes a group of
youths who would beneﬁt from further testing.
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P
rior to 1979, no uniform classiﬁca-
tion of diabetes type existed. To
address this, the National Institutes
of Health assembled an expert committee
that recommended the use of clinical
characteristics, such as age of onset and
“method of treatment” to deﬁne diabetes
type(1).Duelargelytothewidespreadobe-
sity epidemic, however, clinical factors
have become less effective as hallmarks
ofspeciﬁcdiabetesphenotypes(2).More-
over, a classiﬁcation system based on
therapy has become unsatisfactory be-
cause of the increasing clinical trend to-
ward early insulin use regardless of the
presumed diabetes type (2).
In 1997, the American Diabetes As-
sociation (ADA) convened a second ex-
pert committee (2) that proposed a
physiologic framework to classiﬁcation
of diabetes type. The committee con-
cluded that most diabetes cases fell into
two broad categories: type 1, an absolute
deﬁciency of insulin usually attributed to
autoimmune destruction of the b-cells,
and type 2, a combination of insulin re-
sistance and relative insulin deﬁciency.
This framework poses important
practical challenges for researchers and
clinicians because it does not provide
operational deﬁnitions for the markers
used to deﬁne diabetes types (i.e., auto-
immunity, insulin resistance, and insulin
deﬁciency). In addition, it assumes that
there are two distinct diabetes types with
littleornooverlap.Theissueislikelytobe
even more complex for pediatric diabetes
because, until recently, diabetes diag-
nosed in children and adolescents was
almost entirely considered to be type 1
diabetes (2).
SEARCH for Diabetes in Youth is a
multicenter study of pediatric diabetes
in the U.S. This study describes the ap-
proach used in SEARCH to classify
diabetes type using the 1997 ADA frame-
work and to identify youths who require
additional tests to identify speciﬁce t i o l -
ogies. SEARCH used two main etiologic
markers, autoimmunity (measured by
two diabetes-related autoantibodies)
and insulin sensitivity (measured by a
clinical algorithm validated against
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ORIGINAL ARTICLEhyperinsulinemic-euglycemic clamps), to
identify etiologic subgroups of youths
with diabetes. SEARCH then explored
how other characteristics, including ge-
netic susceptibility to autoimmunity,
degree of insulin deﬁciency, and clinical
factors, vary across these categories. This
study describes the development, appli-
cation, strengths, and limitations of this
approach. SEARCH recognizes that de-
ﬁning diabetes type remains difﬁcult and
controversial (3) and that only through
the careful study of large numbers of
youths withdiabetes,notselectedbecause
of their presumed type, can we learn
which characteristics actually differentiate
subgroups of youths with diabetes.
RESEARCH DESIGN AND
METHODS
Overview of SEARCH for
Diabetes in Youth
SEARCH is a multicenter study that con-
ducts population-based ascertainment of
newly diagnosed cases of nongestational
diabetes in youths aged ,20 years (4).
Youths with diabetes were identiﬁed in
deﬁned geographic regions or among
health care management organization
m e m b e r s( 4 ) .F o ra l lc a s e s ,c o r ei n f o r m a -
tion, including date of birth, sex, date of
diagnosis, and diabetes type, were ob-
tained from medical records. Clinical di-
abetes type assigned by the health care
professional was categorized as follows:
type 1 (combining type 1, type 1a, and
type 1b), type 2, and other types (in-
cluding hybrid type, type unknown, and
type designated as other). Self-reported
race and ethnicity data were collected
through a survey using the 2000 U.S.
Census questions (5). Youth with nonse-
condary diabetes were invited to a base-
linestudyvisit.Writteninformedconsent
was obtained observing guidelines estab-
lished by the local institutional review
boards.
Data collection
Study visits occurred after an 8-h over-
night fast. Participants did not take di-
abetes medications the morning of the
visit, and long-acting insulin was admin-
istered the evening before the visit and
then discontinued. Blood was drawn
when subjects were fasting, and a urine
sample was collected. Specimens were
processed locally and shipped within 24 h
to the central laboratory (Northwest Lipid
Metabolism and Diabetes Research Labo-
ratories), where they were analyzed. DNA
was obtained from all consenting par-
ticipants and stored by the central lab-
oratory. Physical examinations were
conducted according to standardized
protocols by trained and certiﬁed staff
members.
Height and weight were measured,
and BMI was calculated and converted to
BMI–z-score using standard Centers for
Disease Controland Prevention approach
(6). Waist circumference was measured
usingtheU.S.NationalHealthandNutrition
Examination Survey (NHANES) protocol
(7). Acanthosis nigricans was documented
using Burke’s method (8). History of in-
sulin use and family history of diabetes in
ﬁrst-degree relativeswere assessed by self-
report. Presence of diabetic ketoacidosis
(DKA) at diabetes onset was based on
medical record abstraction. For DKA to
be present, one of the following criteria
had to be met in the context of hypergly-
cemia: 1) blood bicarbonate ,15 mmol/L
or pH ,7.25 (venous) or ,7.30 (arterial
or capillary), 2) ICD-9 code 250.1 at dis-
charge, and 3) diagnosis of DKA men-
tioned in the medical charts (9).
Laboratory analyses
Samples were analyzed for GAD-65 anti-
bodies(GADA)andinsulinoma-associated-2
antibodies (IA-2A)—using a standardized
protocol (10). The cutoff values for posi-
tivity were 33 National Institute of Dia-
betes and Digestive and Kidney Diseases
Units/mL for GADA and 5 National Insti-
tute of Diabetes and Digestive and Kidney
DiseasesUnits/mLforIA-2A.Thespeciﬁcity
and sensitivity were 97 and 76%, respec-
tively, for GADA and 99 and 64%, respec-
tively, for IA-2A (10). Fasting C-peptide
(FCP) was measured by a two-site immu-
noenzymetric assay (TOSOH Bioscience,
San Francisco, CA). Measurements of se-
rum cholesterol, triglyceride, and HDL
cholesterol were performed on a Hitachi
917 autoanalyzer (Boehringer Mannheim
Diagnostics, Indianapolis, IN). HbA1c
wasmeasuredbya dedicatedion exchange
high–performance liquid chromatography
instrument (TOSOH Bioscience). HLA
class II genotyping (HLA DR-DQ)w a s
performed with a PCR-based sequence–
speciﬁc oligonucleotide probe system in
thelaboratoriesofDrs.L.Gaur(University
ofWashington,Seattle,WA)andH.Erlich
(Roche Molecular Systems, Indianapolis,
IN) on all consenting participants (11).
Operational deﬁnitions
Autoimmunitywasdeﬁnedbypositivetiters
for either GADA or IA-2A. Because many
participants were treated with insulin, in-
sulin autoantibodies were not used.
Insulin sensitivity was estimated using
the following equation:
Insulin sensitivity ¼ exp½4:6472520:02032
3 ðwaist ½cm Þ20:09779
3 ðHbA1c½% Þ20:00235
3 ðtriglyceride ½mg=dL Þ
This equation was developed and val-
idated in a previous study (12) using direct
measurements of glucose disposal rate
(GDR) from euglycemic-hyperinsulinemic
clamps conducted among 88 of the 2,291
SEARCH participants included in this re-
port,inadditionto22matchednondiabetic
control subjects. The major component of
the formula explaining60%ofthe variance
inmeasuredGDRwaswaistcircumference,
regardless of the provider-determined dia-
betes type, race/ethnicity, or case/control
status (12). We used this formula to esti-
mate insulin sensitivity among all 2,291
SEARCH participants. We then established
the range of insulin sensitivity for nondia-
beticyouthbyapplyingtheaforementioned
equation to 2,860 multiracial nondiabetic
youth age 12–20 years participating in
the U.S. National Health and Nutrition
Examination Survey (NHANES) in 1999–
2004. We deﬁned insulin resistance among
SEARCH participants in this study as in-
sulin sensitivity values below the 25th
percentile (insulin sensitivity ,8.15) for
the NHANES youth population.
Insulin deﬁciency was deﬁned as an
FCP value of ,0.4 ng/mL, consistent with
prior SEARCH publications (12) and other
large diabetes studies,including the Diabe-
tes Control and Complications Trial (13).
Genetic susceptibility to autoimmu-
nity was deﬁned based on HLA DR-DQ
genotypes. HLA genotypes were catego-
rized as follows: 1) susceptible, DR3/4
(four genotypes), DR4/4 (four geno-
types), DR4/8 (four genotypes), DR4/1
(one genotype), DR4/13 (one genotype),
DR3/3 (one genotype), DR3/9 (one geno-
type), DR4/9 (two genotypes), and DR9/9
(one genotype); 2) neutral, DR4**/X*,
DR3/X (where X = other non-–high-risk
genotype), DR3/4-non–DQB1*0302,a n d
DR4/DR4-DQB1*0301;a n d3) protec-
tive, DR-0403, DR2-DQB1*0602, DR7-
DQB1*0303,a n dDR14-DQB1*0503,a s
recommended by the Type 1 Diabetes
Genetic Consortium, with modiﬁcations
for the multiethnic population (11).
Statistical analyses
SEARCH participants were cross-classiﬁed
according to measured etiologic markers
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Dabelea and Associatesof diabetes: autoimmunity (present/absent)
and insulin sensitivity (insulin-resistant
[IR]/insulin-sensitive[IS]).Fortheresulting
fourgroups,descriptivestatisticswerecom-
putedforeachvariableofinterest,including
provider-determined diabetes type, HLA
risk categories, presence of absolute insulin
deﬁciency, and demographic, clinical, and
biochemical characteristics. Comparisons
b e t w e e ng r o u p sw i t hn o r m a la n dr e d u c e d
insulin sensitivity within each autoimmu-
nity category were conducted using t tests
or nonparametricmethods(asappropriate)
for continuous variable and x
2 tests for cat-
egorical variables.
RESULTS—The study population con-
sisted of 2,291 youths who were diag-
nosed with diabetes in 2002–2006 at
,20 years of age, who attended a fasting
studyvisit,andwhohadcompletedataon
autoantibodiesandinsulinsensitivity.This
sample included 67.9% non-Hispanic
whites (NHWs), 13.3% Hispanics, 13.4%
African Americans (AAs), 4.1% Asian/
Paciﬁc Islanders (APIs), and 1.3% Ameri-
can Indians (AIs). This group represented
approximately 35% of all SEARCH cases
incident in 2002–2006 and was represen-
tativeintermsofonsetage,sex,andracial/
ethnic distribution of the larger SEARCH
population of registered cases. The AI
population did not provide consent for
storage of genetic samples and therefore
was not included in any genetic analyses.
The prevalence of autoantibody pos-
itivity among study participants was as
follows: 51.8% were positive for GADA,
60.4%werepositiveforIA-2A,73.9%were
positive for either GADA or IA-2A, and
38.2% were positive for both. According
to our deﬁnition of autoimmunity, 1,694
youths (73.9%) were classiﬁed as having
autoimmunediabetes,whereas597(26.1%)
had no evidence of autoimmunity. Accord-
ing to our deﬁnition of IR (i.e., insulin
sensitivity lower than the 25th percentile
for healthy youths), 811 youths (35.4%)
were classiﬁed as IR. This proportion was
signiﬁcantly lower in youths with auto-
immune versus nonautoimmune diabetes
(26.3 vs. 61.1%; P , 0.0001).
Table 1 presents characteristics of
SEARCH participants classiﬁed by both
autoimmunity and insulin sensitivity sta-
tus. This classiﬁcation resulted in four
categories. Two categories were mutually
exclusive in terms of the main etiologic
markers (autoimmune plus IS; non-
autoimmuneplusIR).Theothertwocate-
gories were not mutually exclusive
regarding the main etiologic markers:
one was deﬁned by presence of both
markers (autoimmune plus IR), whereas
the other one was deﬁned by absence of
both etiologic markers (nonautoimmune
plus IS).
Characteristics of individuals in the
four categories
The autoimmune plus IS group was over-
all the largest category, accounting for
54.5% of SEARCH participants. Almost
all of the individuals in this group were
classiﬁed as having type 1 diabetes by
their providers (99.2%). Although only
39.0% had insulin deﬁciency, the clinical
phenotype of these youths supported the
providers’ diagnosis of type 1 diabetes:
78.4% were of NHW origin; the average
age of onset was 9.3 years; there was a
slight excess of male representation
(51.8%), a relatively low BMI z score
(0.4) and prevalence of obesity (i.e., BMI
$95th percentile: 6.8%), and nearly
ubiquitous use of insulin (98.6%); and
29.1% presented in DKA at diabetes on-
set. Furthermore, this group had the low-
estaverageFCPlevelsofthefourcategories
(median 0.5 ng/ml). A total of 547 partic-
ipants (43.8%) had susceptible HLA DR-
DQ genotypes, whereas only 23 (1.8%)
had protective genotypes.
The nonautoimmune plus IR group
accounted overall for 15.9% of SEARCH
participants. Most youths were classiﬁed
as having type 2 diabetes by their pro-
viders (76.4%). In support of the provid-
ers’ diagnosis, these youths had a clinical
phenotypeconsistentwithtype2diabetes
described as follows: 73.4% were of mi-
nority racial/ethnic origin, their average
onset age was around puberty (age 13.9
years), there was an excess of female repre-
sentation (62.5%), a high BMI z score
(2.0), a large waist circumference (age and
sex adjusted 103.1 cm), high prevalence
of obesity (77.6%), high prevalence of
acanthosis (62.6%), less widespread but
frequentuseofinsulin(56.9%),andlower
frequency of DKA at onset (13.1%). The
median FCP was high (3.4 ng/mL), and
only 4.1% had insulin deﬁciency. Only
33 participants (9.0%) had susceptible
HLA DR-DQ genotypes, whereas 53
(14.5%) had protective genotypes.
The autoimmune plus IR group ac-
counted for 19.5% of all SEARCH par-
ticipants. Most youths were classiﬁed as
having type 1 diabetes by their providers
(92.4%). This group had a number of
characteristics that were statistically dif-
ferent from the autoimmune plus IS
group, including older onset age (12.9
vs. 9.3 years; P , 0.0001), a smaller pro-
portion of NHW race/ethnicity (69.1 vs.
78.4%; P , 0.0001), higher BMI z score
(1.2 vs. 0.4, P , 0.0001), higher waist
circumference (age and sex adjusted
83.0vs.67.7cm;P,0.0001),andhigher
prevalence of obesity (33.6 vs. 6.8%; P ,
0.001). However, there was no difference
in the proportion presenting in DKA be-
tween this and the autoimmune plus IS
group and only a clinically modest differ-
enceinproportionwithinsulindeﬁciency
(31.6 vs. 39.0%; P =0 . 0 0 5 ) .M o r e o v e r ,
there were no signiﬁcant differences in
the prevalence and titers of DA or in the
distribution of HLA risk categories be-
tween the two groups.
The nonautoimmune plus IS group
accounted for 10.1% of all SEARCH par-
ticipants. The largest proportion was cat-
egorizedashavingtype1diabetesbytheir
diabetes providers (89.2%). Several char-
acteristics were consistent with type 1 di-
abetes, including prepubertal onset age
(9.4 years), preponderance of NHW race/
ethnicity (74.1%), male overrepresenta-
tion(56.0%),low BMIz score (0.2), waist
circumference (71.7 cm after adjustment
forageandsex),lowprevalenceofobesity
(6.6%), high proportion of insulin use
(91.3%), and high proportion presenting
in DKA (23.1%). With the exception of
the lack of autoimmunity, all other char-
acteristics were signiﬁcantly different
from those exhibited by the nonautoim-
mune plus IR group. Regarding HLA ge-
notypes,24.6%hadsusceptibleand6.5%
had protective genotypes.
Figure 1 presents the proportional dis-
tribution of the four categories described
above among NHW, Hispanic, AA, API,
and AI participants. There were important
differences across the racial/ethnic groups.
The autoimmune plus IS group was the
majorcategory among NHW andHispanic
participants, while the nonautoimmune
plus IR group accounted for most diabetes
cases among AA, API, and AI individuals.
The main variation across racial/ethnic
groups resulted from distributional differ-
ences of the two etiologically distinct cate-
gories (i.e., autoimmune plus IS and
nonautoimmune plus IR) rather than dif-
ferences in the proportional distribution of
the two less distinct groups (autoimmune
plus IR and nonautoimmune plus IS).
CONCLUSIONS
Main ﬁndings
Thereareﬁvemajorﬁndingsofthisstudy.
1) Most youths ,20 years of age with
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Etiological approach to diabetes type characterizationdiabetesfellintocategoriesthatalignwith
traditionaldescriptionsoftype1(autoim-
mune plus IS) and type 2 diabetes (non-
autoimmune plus IR). 2)Asexpected,the
proportional distribution of these groups
varied substantially across racial/ethnic
groups.3)Thegroupclassiﬁedasautoim-
mune plus IR is likely to represent indi-
viduals with type 1 autoimmune diabetes
andobesity,agroupthatisexpandingasa
result of the recent increase in the fre-
quency of obesity but that is not a new
etiologic entity. 4)T h eg r o u pc l a s s i ﬁed
as nonautoimmune plus IS represents an
etiologically mixed category and requires
furthertesting.5)Forthepurposeofpub-
lic health surveillance, the provider
assignment of diabetes type agrees well
with the etiological assessment, at least
for cases that ﬁt the typical picture of
type 1 and type 2 diabetes.
The autoimmune plus IS group had
clinical characteristics that were consis-
tent with the traditional description of
type1diabetes,includingprepubertalage
of onset, absence of obesity, and wide-
spread insulin use (14). A total of 43.8%
had susceptible HLA DR-DQ genotypes—
a proportion similar to that reported
among white youths and young adults
with type 1 diabetes from Europe (15)
and Australia (16). These data suggest
that the presence of susceptible HLA
DR-DQ g e n o t y p e si sn o tan e c e s s a r y
condition for the development of autoim-
mune diabetes in youth. Consistent with
prior clinical trials (17), 61% of youths in
this group have preserved b-cell secretion
(FCP $ 0.4 ng/mL) within the ﬁrst year of
diagnosis. This challenges the paradigm
that type 1 diabetes is a state of absolute
insulin deﬁciency in youths with diabetes
at short duration and recommends the
use of FCP as a physiological descriptor
of disease status and evolution rather
than a marker of disease etiology.
At the other extreme of our bidi-
mensional etiologic spectrum, the
non-autoimmune plus IR group had
characteristics that were consistent with the
current description of early-onset type 2
Table 1—Characteristics of SEARCH participants according to autoimmunity and insulin sensitivity status
Autoimmune Nonautoimmune
IS IR P IS IR P
N (%) 1,248 (54.5) 446 (19.5) 232 (10.1) 365 (15.9)
Clinical diabetes type, N (%) , 0.001 ,0.001
Type 1 diabetes 1,238 (99.2) 412 (92.4) 207 (89.2) 86 (23.6)
Type 2 diabetes/other 10 (0.8) 34 (7.6) 25 (10.8) 279 (76.4)
HLA risk category, N (%)* 0.12 ,0.001
Susceptible 547 (43.8) 173 (38.8) 57 (24.6) 33 (9.0)
Neutral 567 (45.4) 232 (52.0) 130 (56.0) 236 (64.7)
Protective 23 (1.8) 8 (1.8) 15 (6.5) 53 (14.5)
Insulin deﬁciency (FCP ,0.4 ng/mL), N (%) 487 (39.0) 141 (31.6) 0.005 75 (32.3) 15 (4.1) ,0.001
Demographic characteristics
NHW, N (%) 979 (78.4) 308 (69.1) ,0.001 172 (74.1) 97 (26.6) ,0.001
Onset age (years) 9.3 6 3.7 12.9 6 2.8 ,0.001 9.4 6 4.1 13.9 6 2.6 ,0.001
Onset age ,10 years, N (%) 660 (52.9) 49 (11.0) ,0.001 117 (50.4) 17 (4.7) ,0.001
Current age (years) 10.4 6 3.7 14.2 6 2.9 ,0.001 10.5 6 4.1 15.1 6 2.7 ,0.001
Diabetes duration (months) 9.6 6 5.9 11.5 6 6.6 ,0.001 10.0 6 6.2 11.3 6 6.9 0.03
Male, N (%) 646 (51.8) 218 (48.9) 0.30 130 (56.0) 137 (37.5) ,0.001
Family history of diabetes, N (%)* 155 (15.9) 74 (21.8) 0.014 41 (22.9) 155 (52.5) ,0.001
Clinical characteristics
BMI z score* 0.4 6 0.9 1.2 6 0.9 ,0.001 0.2 6 1.0 2 6 0.8 ,0.001
BMI percentiles, N (%)* ,0.001 ,0.001
,85 961 (77.3) 161 (36.3) 179 (78.5) 35 (9.7)
85–95 197 (15.8) 134 (30.2) 34 (14.9) 46 (12.7)
$95 85 (6.8) 149 (33.6) 15 (6.6) 281(77.6)
Waist (cm)† 67.7 6 0.3 83.0 6 0.5 ,0.001 71.7 6 1.1 103.1 6 0.9 ,0.001
Acanthosis, N (%)* 27 (2.2) 51 (11.8) ,0.001 9 (3.9) 221(62.6) ,0.001
Insulin use, N (%)* 1,228 (98.6) 422 (94.6) ,0.001 210 (91.3) 207 (56.9) ,0.001
DKA at onset, N (%)* 270 (29.1) 98 (29.9) 0.79 39 (23.1) 36 (13.1) 0.007
Biochemical characteristics
FCP (ng/mL), median (25th–75th) 0.5 (0.2–0.9) 0.7 (0.3–1.4) ,0.001 0.6 (0.3–1.2) 3.4 (1.9–4.8) ,0.001
IS score 11.9 6 2.4 6.3 6 1.5 ,0.001 12.2 6 3.0 4.5 6 1.8 ,0.001
GADA-positive, N (%) 859 (68.8) 327 (73.3) 0.08 —— N/A
GADA titers, median (25th–75th) 103.4 (16.3–418.5) 106.6 (26.2–397.4) 0.45 0 (0–8.2) 0 (0–0) N/A
IA-2A positive, N (%) 1,032 (82.7) 351 (78.7) 0.06 —— N/A
IA-2A titers, median (25th–75th) 233.3 (29.7–438.3) 290.7 (13.5–452.5) 0.50 0 (0–0) 0 (0–0) N/A
GADA and IA-2A positive, median
(25th–75th) 643 (51.5) 232 (52.0) 0.86 —— N/A
Data are means 6 SD unless otherwise noted. P for associations between IR and IS within each autoimmunity category. N/A, not applicable. *Missing values.
†Adjusted for age and sex.
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Dabelea and Associatesdiabetes, including pubertal age of onset,
obesity and other markers of IR, female
excess, strong family history, and prepon-
derance of minority racial/ethnic represen-
tation (18). Consistent with other reports
(19), insulin use was quite frequent (56.9%)
and, therefore, not a good surrogate for
etiologic classiﬁcation. The proportion
with susceptible HLA DR-DQ genotypes
(9.0%) was similar to that seen among
200 nondiabetic young adults in the UK
Prospective Diabetes tudy (9%) (20), pro-
viding indirect evidence that this diabetes
phenotype isunlikelytobeassociatedwith
autoimmunity.Atotalof95.9%ofyouthin
this group had clinically signiﬁcant resid-
ual b-cell secretion, suggesting a less ag-
gressive b-cell loss than the other groups.
In addition to the two categories
above, which support the ADA notion
that most diabetes cases fall into two dis-
tinct categories, our approach allowed
the characterization of less distinct etio-
logic categories. The autoimmune plus
IR group was speciﬁcally designed to
identify individuals with evidence of
both autoimmunity and insulin resistance.
Investigators and clinicians have previ-
ously described this group as having “hy-
brid” diabetes (21), suggesting a mixed
etiology. However, this group had many
features that were observed in the auto-
immune plus IS group and aligned with
traditionalcharacteristicsoftype1diabe-
tes. Speciﬁcally, there was a similar prev-
alence and titers of autoantibodies and
similar distribution of HLA DR-DQ risk
genotypes, suggesting similar contribu-
tions of immune-mediated disease pro-
cesses. In addition, and importantly,
this group represented 26.3% of all auto-
immune case subjects. This proportion is
not higher than expected, given that our
deﬁnitionofinsulinresistanceisbasedon
the lowest 25th percentile in the general
population. Therefore, our data suggest
that this group is not a distinct etiologic
category but, rather, the upper tail of the
distributionofinsulinresistanceandobe-
sity among youths with autoimmune di-
abetes. Nevertheless, because this is a
nontraditional presentation of type 1 di-
abetes in youth, the study of this group’s
clinical course, including the develop-
ment of diabetes-related complications,
is of considerable interest.
The last category, characterized by
absence of both etiological markers of di-
abetes (nonautoimmune plus IS group),
had several characteristics associated with
type1autoimmunediabetes,including an
overrepresentation of susceptible HLA
DR-DQ genotypes (24.6%) compared
with the general population (9%) (20). It
ispossiblethatsomepatientsinthisgroup
have seroconverted to antibody negativity
(22) or present other immune markers
thanthosecurrentlymeasured,suchasin-
sulin autoantibodies (23) or the recently
discovered autoantibody against Zinc
transporter 8 (ZnT8) (24). This group
may also include individuals with single-
gene mutations affecting b-cell function,
historically referred to as maturity-onset
diabetes of the young (MODY). Prelimi-
narySEARCHdatasuggestthatmostcases
with single gene mutations in HNF1-a,
HNF4-a,o rglucokinase-MODY present
with a phenotype consisting of insulin
sensitivity and neutral/protective HLA
genotypes (25).
Limitations and strengths
This study has a number of limitations.
First, only two autoantibodies were mea-
sured. Thus, individuals having auto-
immune markers other than GADA or
IA-2A were misclassiﬁed as having non-
autoimmune diabetes. Unpublished data
in a sample of SEARCH participants sug-
gest that almost 20% of youths who are
negative for GADA and IA-2A are positive
for ZnT8, which is why we are planning
to measure ZnT8 antibodies in stored
samplesonceassaysarestandardized.How-
ever, the timing of autoantibody measure-
ments is unlikely to have affected our
ﬁndings because, in a sample of SEARCH
participants, the prevalence of DA positiv-
ity (positive GADA and/or IA-2A) was
similar at diabetes onset (73.3%) and at
the SEARCH visit (75.4%). Second, we
chose the bottom 25th percentile of esti-
mated insulin sensitivity among NHANES
youth age 12–20 years to deﬁne insulin
resistance. Because of the known effect of
puberty decreasing insulin sensitivity, the
25th percentile for the insulin sensitivity
index in the NHANES group may have
overestimatedthenumberofSEARCHpar-
ticipantsage,12yearswhowereclassiﬁed
as IR. However, only 155 SEARCH partic-
ipantsage,12years(6.8%)wereclassiﬁed
as IR. In addition, we recognize that this is
an arbitrary cut point based on percentile
distribution of a surrogate marker of insu-
lin sensitivity in the general population.
However,analysesusingdifferentcutpoints
forinsulinsensitivity(e.g.,bottom15thper-
centile) or waist circumference only (the
major component of the insulin sensitivity
equation) resulted in similar group charac-
teristics. Finally, etiologic markers of dia-
betes type are inﬂuenced by a variety of
factors, including diabetes duration and
glycemic control, so characteristics de-
scribed here represent cross-sectional as-
s e s s m e n t so fd i a b e t e sp h e n o t y p e si n
youths with short disease duration.
Despite these limitations, this study
has a number of strengths. Unlike most
other childhood diabetes registries, this
large multiethnic cohort has been ascer-
tainedwithoutregardtopresumeddiabetes
type or related factors, such as treatment,
age, or race/ethnicity. Using diabetes
Figure1—ProportionaldistributionofetiologiccategoriesamongSEARCHparticipantsbyrace/
ethnicity
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Etiological approach to diabetes type characterizationautoantibodies and an algorithm to assess
insulinsensitivitybasedonroutineclinical
measures, this approach classiﬁes .90%
of youths with new-onset diabetes into
one of the traditional categories, consis-
tent with the current nomenclature of
type 1 (evidence of autoimmunity regard-
lessofinsulinsensitivitystatus)andtype2
diabetes(noautoimmunityandinsulinre-
sistance). The SEARCH study thus offers
researchers and clinicians a practical ap-
plication for the etiologic classiﬁcation of
diabetestype,atthesametimeidentifyinga
group of youths (those with insulin sensi-
tivity without evidence of autoimmunity)
who would beneﬁt from further testing
(novel autoantibodies, metabolic proﬁling,
andgenetictestingformonogenicdiabetes)
to further elucidate the etiology.
In summary, to our knowledge, this
study is the ﬁr s ta t t e m p tt op r o v i d eo p e r a -
tional deﬁnitions of types of diabetes using
anetiologicalapproach,asrecommended
by the ADA expert committee. SEARCH
is planning to use this approach to better
describe the changing epidemiology of pe-
diatric diabetes, to evaluate public health
surveillance systems for diabetes in children,
and to explore novel hypotheses about the
effect of diabetes type on the development
of diabetes-related health outcomes.
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